Alexandre Puissant

Title: The Innovations of Alexandre Puissant

Introduction

Alexandre Puissant is a notable inventor based in Nice, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of therapeutic agents for cancer treatment. His work focuses on innovative compounds that have the potential to improve patient outcomes.

Latest Patents

One of Alexandre Puissant's key patents is titled "Acadesine derivatives, products and compositions including same, therapeutic uses thereof, and methods for synthesizing same." This patent describes Acadesine derivatives as a drug, specifically targeting the treatment of cancer, including chronic myeloid leukemia. The patent outlines the use of these derivatives in combination with at least one other active ingredient for simultaneous, separate, or sequential administration in cancer treatment. Additionally, it details a pharmaceutical composition containing these derivatives and a pharmaceutically acceptable carrier. The patent also includes methods for inhibiting in vitro cell proliferation by placing cells in contact with the derivatives, as well as methods for synthesizing these compounds.

Career Highlights

Throughout his career, Alexandre Puissant has been associated with prestigious institutions such as Université Nice Sophia Antipolis and the Centre National de la Recherche Scientifique. His work in these organizations has allowed him to advance his research and contribute to the scientific community.

Collaborations

Alexandre has collaborated with esteemed colleagues, including Rachid Benhida and Patrick Auberger. These partnerships have fostered a collaborative environment that enhances the research and development of innovative therapeutic solutions.

Conclusion

In summary, Alexandre Puissant is a distinguished inventor whose work in developing Acadesine derivatives has the potential to significantly impact cancer treatment. His contributions to the field of pharmaceuticals demonstrate the importance of innovation in addressing critical health challenges.